CompanyOVIDNasdaqNew York, NY

Ovid Therapeutics Inc.

Ovid Therapeutics develops small molecule medicines for neurological and neuropsychiatric disorders.

SEC EDGAR ClinicalTrials.gov ovidrx.com

SCHEDULE 13G/AAug 14Latest SEC filing

Jul 8Latest story

July 2026

Ovid Therapeutics names Charles Carter CFO as Jeffrey Rona departs

Jul 8PeopleOvid Therapeutics Inc.